MDXH vs NDRA

MDxHealth SA vs ENDRA Life Sciences Inc. — Valuation Comparison 2026

MDXH

Diagnostics & Research
MDxHealth SA
Quality
1.7
out of 10
Value Trap
Price
$0.75
Last close
Models
8/13
Active
VS

NDRA

Diagnostics & Research
ENDRA Life Sciences Inc.
Quality
3.6
out of 10
Value Trap
39
LOW
Price
$5.52
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType MDXH Fair ValueMDXH Upside NDRA Fair ValueNDRA Upside
Bayesian DCF Intrinsic $0.20 -73.5% $1.48 -73.1%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.27 +69.2% $9.42 +70.7%
PWERM Option-Based $2.01 +167.8% $6.19 +12.2%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for MDXH vs NDRA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MDXH vs NDRA — Which Stock Is More Undervalued?

NDRA scores higher with a 3.6/10 quality rating vs MDXH's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing MDxHealth SA (MDXH) and ENDRA Life Sciences Inc. (NDRA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MDXH currently trades at $0.75 with a QOC of 1.7/10, while NDRA trades at $5.52 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).